首页|复脉辈方治疗心系疾病的研究进展

复脉辈方治疗心系疾病的研究进展

扫码查看
温病学说源远流长,其学术思想不仅能指导外感性疾病的治疗,在心系疾病的临床治疗中亦发挥了重要作用.清代吴鞠通在《温病条辨》中所载复脉辈方有:加减复脉汤、一甲复脉汤、二甲复脉汤、三甲复脉汤、大定风珠等,都是在复脉汤的基础上化裁而成.复脉辈方虽常被用于治疗温病后期肝肾阴亏之证,但因其具有滋阴潜阳、温阳益气、调整阴阳作用,对心律失常、心力衰竭、高血压等心系疾病有较好的疗效.通过系统梳理复脉辈方的源流和在心系疾病治疗方面的临床研究进展,并从药理学角度解读复脉辈方,提炼其临床经验与成果,以期为进一步挖掘复脉辈方在心系疾病治疗中的优势,为心病的临床实践提供理论基础.
Research progress of Fumai-based prescriptions in the treatment of heart system diseases
The theory of warm diseases has a long history and profound influence.Its academic principles not only guide the treatment of exogenous diseases but also play a significant role in the clinical treatment of heart system diseases.Wenbing Tiaobian(Detailed Analysis of Epidemic Warm Diseases),created by Wu Jutong in the Qing Dynasty,recorded several modified prescriptions under the category of Fumai generation formulas,such as modified Fumai Decoction,Yijia Fumai Decoction,Erjia Fumai Decoction,Sanjia Fumai Decoction,and Da Dingfeng Zhu.Although these Fumai-based prescriptions are commonly used to treat the syndrome of yin deficiency of both the liver and kidney in the late stage of warm diseases,they are also effective in treating arrhythmia,heart failure,hypertension,and other heart system diseases due to their effects of nourishing yin for suppressing hyperactive yang,warming yang and benefiting qi,and regulating yin and yang.This article systematically reviews the origins and development of Fumai-based prescriptions and their clinical research progress in the treatment of cardiovascular diseases.It also interprets these prescriptions from a pharmacological perspective,extracting their clinical experiences and achievements,aiming to further explore the advantages of Fumai-based prescriptions in the treatment of cardiovascular diseases and provide a solid theoretical basis for the clinical practice in the treatment of heart system diseases.

Fumai generation formulasheart system diseaseswarm diseasesresearch progress

温永梅、王丽莎、王晶、常天瀛、崔英子

展开 >

长春中医药大学附属医院,长春 130021

长春中医药大学,长春 130117

复脉辈方 心系疾病 温病 研究进展

长春中医药大学附属医院中医药循证能力提升项目(2024)

2024

吉林中医药
长春中医药大学

吉林中医药

CSTPCD
影响因子:0.843
ISSN:1003-5699
年,卷(期):2024.44(9)